BAJAJ BROKING

Notification
No new Notification messages
Hexaware Technologies IPO is Open!
Apply for the Hexaware Technologies IPO through UPI in just minutes.
Q3 FY'25 Results of Top Companies!
From Reliance Industries to TCS to HDFC Bank, check out the latest quarterly results with financial highlights, key performance metrics, and more!
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
strides pharma sci ltd stock

STRIDES PHARMA SCI LTD Share Price

645.2 -34.50 (-5.07%)
14 Feb 2025 | 03:30 PM Pharmaceuticals NSE: STAR

STRIDES PHARMA SCI LTD Share Price Update

As of the latest trading session, STRIDES PHARMA SCI LTD share price is currently at 645.2, which is down by -34.50 from its previous closing. Today, the stock has fluctuated between 624.50 and 690.50. Over the past year, STRIDES PHARMA SCI LTD has achieved a return of 82.49 %. In the last month alone, the return has been 3.32 %. Read More...

STRIDES PHARMA SCI LTD Performance

Day Range

Low624.50 High690.50
645.20

52 Week Range

Low 530.00 High 1675.00
645.20

STRIDES PHARMA SCI LTD Share Price

7374

532531

STAR

img img img img
No Data Available

Open Price

685.00

Prev. Close

679.70

Volume (Shares)

1225649.00

Total traded value

7907.88

Upper Circuit

815.60

Lower Circuit

543.80

Note: The current prices & values are delayed, Login to your account for live updates.

STRIDES PHARMA SCI LTD Fundamentals


(Standalone)

Market Cap (Cr) 5929.37
PE Ratio (TTM) 67.10
Book Value / Share 381.62
Beta 0.80
ROE 1.87%
EPS (TTM) 9.59
Dividend Yield 0.39%
Net Profit Qtr (Cr) 14.94

STRIDES PHARMA SCI LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 550.92
Operating Expense 531.95
Net Profit 14.94
Net Profit Margin (%) 2.71
Earnings Per Share (EPS) 1.62
EBITDA 76.51
Effective Tax Rate (%) 30.12
Particulars SEP 2024 (Values in Cr)
Revenue 519.55
Operating Expense 526.71
Net Profit 17.26
Net Profit Margin (%) 3.32
Earnings Per Share (EPS) 1.88
EBITDA 78.91
Effective Tax Rate (%) -5.37
Particulars JUN 2024 (Values in Cr)
Revenue 585.95
Operating Expense 590.48
Net Profit 2.40
Net Profit Margin (%) 0.40
Earnings Per Share (EPS) 0.26
EBITDA 73.86
Effective Tax Rate (%) 32.77
Particulars MAR 2024 (Values in Cr)
Revenue 617.63
Operating Expense 594.42
Net Profit 53.66
Net Profit Margin (%) 8.68
Earnings Per Share (EPS) 5.84
EBITDA 120.36
Effective Tax Rate (%) -1.68
Particulars DEC 2023 (Values in Cr)
Revenue 379.64
Operating Expense 435.93
Net Profit -0.38
Net Profit Margin (%) -0.10
Earnings Per Share (EPS) -0.04
EBITDA 1.07
Effective Tax Rate (%) -6.35
Particulars MAR 2024 (Values in Cr)
Revenue 1866.12
Operating Expense 1942.40
Net Profit 44.55
Net Profit Margin (%) 2.38
Earnings Per Share (EPS) 4.89
EBITDA 203.85
Effective Tax Rate (%) -5.84
Particulars MAR 2023 (Values in Cr)
Revenue 1854.50
Operating Expense 1988.32
Net Profit 4.68
Net Profit Margin (%) 0.25
Earnings Per Share (EPS) 0.52
EBITDA 167.54
Effective Tax Rate (%) 107.22
Particulars MAR 2022 (Values in Cr)
Revenue 1979.00
Operating Expense 2080.98
Net Profit 180.19
Net Profit Margin (%) 9.10
Earnings Per Share (EPS) 20.08
EBITDA 200.12
Effective Tax Rate (%) -737.70
Particulars MAR 2021 (Values in Cr)
Revenue 1857.57
Operating Expense 1834.92
Net Profit 78.24
Net Profit Margin (%) 4.21
Earnings Per Share (EPS) 8.73
EBITDA 276.32
Effective Tax Rate (%) 29.91
Particulars MAR 2020 (Values in Cr)
Revenue 1691.93
Operating Expense 1648.56
Net Profit 120.28
Net Profit Margin (%) 7.10
Earnings Per Share (EPS) 13.43
EBITDA 297.53
Effective Tax Rate (%) 11.85
Particulars MAR 2024 (Values in Cr)
Book Value / Share 231.28
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.28
EBITDA Margin 14.93
Particulars MAR 2023 (Values in Cr)
Book Value / Share 243.09
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.32
EBITDA Margin 6.42
Particulars MAR 2022 (Values in Cr)
Book Value / Share 262.70
ROE % -9.42
ROCE % -4.44
Total Debt to Total Equity 1.05
EBITDA Margin -0.34
Particulars MAR 2021 (Values in Cr)
Book Value / Share 309.62
ROE % 8.14
ROCE % 7.59
Total Debt to Total Equity 0.86
EBITDA Margin 18.06
Particulars MAR 2020 (Values in Cr)
Book Value / Share 282.19
ROE % 3.13
ROCE % 4.90
Total Debt to Total Equity 1.05
EBITDA Margin 16.34
Particulars MAR 2024 (Values in Cr)
Book Value / Share 387.49
ROE % 1.87
ROCE % 4.68
Total Debt to Total Equity 0.44
EBITDA Margin 14.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 380.71
ROE % 0.61
ROCE % 1.87
Total Debt to Total Equity 0.39
EBITDA Margin 9.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 379.36
ROE % 5.29
ROCE % 1.87
Total Debt to Total Equity 0.33
EBITDA Margin 9.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 362.18
ROE % 2.44
ROCE % 4.18
Total Debt to Total Equity 0.28
EBITDA Margin 14.88
Particulars MAR 2020 (Values in Cr)
Book Value / Share 352.68
ROE % 3.75
ROCE % 4.98
Total Debt to Total Equity 0.27
EBITDA Margin 17.59
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 191.16
Total Assets 5839.75
Total Liabilities 5839.75
Total Equity 2071.70
Share Outstanding 91899714
Price to Book Ratio 2.02
Return on Assets (%) -1.20
Return on Capital (%) -1.57
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 315.96
Total Assets 6638.42
Total Liabilities 6638.42
Total Equity 2172.88
Share Outstanding 90302704
Price to Book Ratio 0.75
Return on Assets (%) -3.05
Return on Capital (%) -4.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 187.35
Total Assets 6975.86
Total Liabilities 6975.86
Total Equity 2383.31
Share Outstanding 89790214
Price to Book Ratio 0.91
Return on Assets (%) -6.59
Return on Capital (%) -8.89
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 179.76
Total Assets 7015.02
Total Liabilities 7015.02
Total Equity 2814.00
Share Outstanding 89680964
Price to Book Ratio 2.33
Return on Assets (%) 3.82
Return on Capital (%) 5.46
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 237.09
Total Assets 6151.73
Total Liabilities 6151.73
Total Equity 2594.65
Share Outstanding 89565464
Price to Book Ratio 0.91
Return on Assets (%) 0.59
Return on Capital (%) 0.82
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 111.83
Total Assets 5837.78
Total Liabilities 5837.78
Total Equity 3561.12
Share Outstanding 91899714
Price to Book Ratio 2.02
Return on Assets (%) 1.12
Return on Capital (%) 1.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 85.58
Total Assets 5619.74
Total Liabilities 5619.74
Total Equity 3455.05
Share Outstanding 90302704
Price to Book Ratio 0.75
Return on Assets (%) 0.08
Return on Capital (%) 0.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 14.44
Total Assets 5433.85
Total Liabilities 5433.85
Total Equity 3406.68
Share Outstanding 89790214
Price to Book Ratio 0.91
Return on Assets (%) 3.31
Return on Capital (%) 3.87
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 73.04
Total Assets 5221.33
Total Liabilities 5221.33
Total Equity 3248.05
Share Outstanding 89680964
Price to Book Ratio 2.33
Return on Assets (%) 1.49
Return on Capital (%) 1.9
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 109.89
Total Assets 4676.86
Total Liabilities 4676.86
Total Equity 3158.78
Share Outstanding 89565464
Price to Book Ratio 0.91
Return on Assets (%) 2.57
Return on Capital (%) 3
Particulars MAR 2024 (Values in Cr)
Net Income -62.72
Cash from Operations 676.81
Cash from Investing -150.25
Cash from Financing -693.32
Net change in Cash -142.50
Free Cash Flow 794.96
Particulars MAR 2023 (Values in Cr)
Net Income -267.63
Cash from Operations -43.23
Cash from Investing 302.47
Cash from Financing -213.92
Net change in Cash 132.96
Free Cash Flow 51.70
Particulars MAR 2022 (Values in Cr)
Net Income -652.51
Cash from Operations -260.14
Cash from Investing -118.73
Cash from Financing 421.31
Net change in Cash 44.76
Free Cash Flow -116.75
Particulars MAR 2021 (Values in Cr)
Net Income 289.38
Cash from Operations 324.64
Cash from Investing -520.82
Cash from Financing -15.79
Net change in Cash -55.18
Free Cash Flow 622.12
Particulars MAR 2020 (Values in Cr)
Net Income 48.50
Cash from Operations 249.76
Cash from Investing 1306.15
Cash from Financing -1709.44
Net change in Cash -198.50
Free Cash Flow 399.76
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 48.41 27.82 2.64 370.98 39.20 / 77.70
BLISS GVS PHARMA LTD 132.25 17.33 1.37 1393.52 92.25 / 184.95
CIPLA LTD 1459.05 23.62 4.15 117834.93 1317.60 / 1702.00
FERMENTA BIOTECH LIMITED 298.95 24.77 3.03 879.84 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 48.41 42.10 8.23 370.98 39.20 / 77.70
AMRUTAJAN HEALTH LTD 612.45 35.90 5.94 1770.63 591.10 / 861.40
ASTRAZENECA PHARMA IND LT 7096.35 105.84 26.11 17740.88 4050.15 / 8139.85
BLISS GVS PHARMA LTD 132.25 17.18 1.36 1393.52 92.25 / 184.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 675.90
  • 26 Days 669.10
  • 10 Days 680.90
  • 50 Days 663.40
  • 12 Days 679.40
  • 100 Days 640.70
  • 20 Days 672.30
  • 200 Days 571.00
684.83
PIVOT
First Resistance 700.67
Second Resistance 721.63
Third Resistance 737.47
First Support 663.87
Second Support 648.03
Third Support 627.07
RSI 46.07
MACD 10.21
Commodity Channel Index (CCI) -3.79
ADX 13.51
Williams % R -59.06

Over 1 Month

down

3.32

Over 3 Months

down

4.03

Over 6 Months

down

20.06

Over 1 Year

down

82.49

Over 3 Years

down

60.14

Over 5 Years

down

22.66

STRIDES PHARMA SCI LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

STRIDES PHARMA SCI LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
27.77
Promoter Holdings
26.82
FII
28.48
DII
16.92
Promoter Shares(Pledge Percentage)
54.25
Name Category Shares Shares%
Pronomz Ventures Llp Shareholding of Promoter and Promoter Group 1.6789564E7 18.22
Quant Mutual Fund - Quant Business Cycle Fund Public Shareholding 4977936.0 5.4
Route One Offshore Master Fund, L.p. Public Shareholding 4653310.0 5.05
Karuna Business Solutions Llp Shareholding of Promoter and Promoter Group 3225050.0 3.5
Sbi Life Insurance Co. Ltd Public Shareholding 2053068.0 2.23
Route One Fund I, L.p. Public Shareholding 1997344.0 2.17
Arun Kumar Pillai Shareholding of Promoter and Promoter Group 1960687.0 2.13
Amansa Holdings Private Limited Public Shareholding 1597251.0 1.73
Morgan Stanley Asia (singapore) Pte. - Odi Public Shareholding 1490381.0 1.62
Satpal Khattar Public Shareholding 1474942.0 1.6
Axis Mutual Fund Trustee Limited A/caxis Mutual F Public Shareholding 1423227.0 1.54
Aditya Birla Sunlife Trustee Private Limited A/c Public Shareholding 1320446.0 1.43
K R Ravishankar Shareholding of Promoter and Promoter Group 1255593.0 1.36
Bnp Paribas Financial Markets - Odi Public Shareholding 1227518.0 1.33
Mukul Mahavir Agrawal Public Shareholding 1066000.0 1.16
Oman India Joint Investment Fund Ii Public Shareholding 1011103.0 1.1
Max Life Insurance Company Limited A/c Reversionar Public Shareholding 955303.0 1.04
Agraganya Private Trust (trustee: Barclay Wealth Trustees (i) Pvt Ltd) Shareholding of Promoter and Promoter Group 300000.0 0.33
Ambemata Securities Shareholding of Promoter and Promoter Group 240860.0 0.26
Vineetha Mohanakumar Pillai Shareholding of Promoter and Promoter Group 190000.0 0.21
Padmakumar Karunakaran Pillai Shareholding of Promoter and Promoter Group 186485.0 0.2
Shasun Enterprises Llp (formerly, Devendra Estates Llp) Shareholding of Promoter and Promoter Group 156451.0 0.17
K R Lakshmi Shareholding of Promoter and Promoter Group 130365.0 0.14
Sajitha Pillai Shareholding of Promoter and Promoter Group 95000.0 0.1
Hemalatha Pillai Shareholding of Promoter and Promoter Group 66760.0 0.07
Rajitha Gopalakrishnan Shareholding of Promoter and Promoter Group 60000.0 0.07
Aditya Arun Kumar Shareholding of Promoter and Promoter Group 58422.0 0.06
Anuradha K R Shareholding of Promoter and Promoter Group 5470.0 0.01
Triumph Venture Holdings Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Karuna Ventures Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Chayadeep Properties Private Ltd Shareholding of Promoter and Promoter Group 0.0 0.0
Agnus Holdings Pvt Ltd Shareholding of Promoter and Promoter Group 0.0 0.0
Agnus Capital Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Abusha Investment & Manangement Services Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Shasun Leasing And Finance (p) Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Tarini Arun Kumar Shareholding of Promoter and Promoter Group 0.0 0.0
Rajeswari Amma Shareholding of Promoter and Promoter Group 0.0 0.0
Deepa Arun Kumar Shareholding of Promoter and Promoter Group 0.0 0.0

STRIDES PHARMA SCI LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-08-04 1.5 Final 2023-08-04 Equity shares 2021-08-05 2.5 Final 2021-08-06 Equity shares 2020-07-24 2.0 Final 2020-07-27 Equity shares 2019-08-22 12.0 Interim 2019-08-23 Equity shares 2019-07-19 3.0 Final 2019-07-23 Equity shares 2018-09-12 2.0 Final 2018-09-15 Equity shares 2017-09-07 4.5 Final 2017-09-09 Equity shares 2016-07-21 4.0 Final 2016-07-23 Equity shares 2015-07-22 3.0 Final 2015-07-24 Equity shares 2014-10-16 105.0 Special 2014-10-17 Equity shares 2014-09-01 5.0 Final 2014-09-03 Equity shares 2013-12-19 500.0 Special 2013-12-20 Equity shares 2013-05-30 2.0 Final 2013-06-03 Equity shares 2012-05-14 2.0 Final 2012-05-16 Equity shares 2011-05-18 1.5 Final 2011-05-20 Equity shares 2010-05-21 1.5 Final 2010-05-25 Equity shares 2007-06-12 2.0 Final 2007-06-14 Equity shares 2006-06-06 0.0 Final 0001-01-01 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About STRIDES PHARMA SCI LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by STRIDES PHARMA SCI LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Strides Pharma Science Ltd?

Answer Field

The share price of Strides Pharma Science Ltd for NSE is ₹ 645.2 and for BSE is ₹ 630.

What is the Market Cap of Strides Pharma Science Ltd?

Answer Field

The market cap of Strides Pharma Science Ltd for NSE is ₹ 59,29.37 Cr. and for BSE is ₹ 57,89.68 Cr. as of now.

What is the 52 Week High and Low of Strides Pharma Science Ltd?

Answer Field

The 52 Week High and Low of Strides Pharma Science Ltd for NSE is ₹ 760.95 and ₹ 301.13 and for BSE is ₹ 785.85 and ₹ 301.04.

How to Buy Strides Pharma Science Ltd share?

Answer Field

You can trade in Strides Pharma Science Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Strides Pharma Science Ltd?

Answer Field

The 1 year returns on the stock has been 0.0%.

What is the Current Share Price of Strides Pharma Science Ltd?

Answer Field

Strides Pharma Science Ltd share price is for NSE ₹ 645.2 & for BSE ₹ 630 as on 14 Feb 2025 | 03:30 PM.

What is the Market Cap of Strides Pharma Science Ltd Share?

Answer Field

The market cap of Strides Pharma Science Ltd for NSE ₹ 59,29.37 & for BSE ₹ 57,89.68 as on 14 Feb 2025 | 03:30 PM.

What is the P/E Ratio of Strides Pharma Science Ltd Share?

Answer Field

As on 14 Feb 2025 | 03:30 PM the price-to-earnings (PE) ratio for Strides Pharma Science Ltd share is 67.10.

What is the PB ratio of Strides Pharma Science Ltd Share?

Answer Field

As on 14 Feb 2025 | 03:30 PM, the price-to-book (PB) ratio for Strides Pharma Science Ltd share is 381.62.

How to Buy Strides Pharma Science Ltd Share?

Answer Field

You can trade in Strides Pharma Science Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Strides Pharma Science Ltd Share on Bajaj Broking App?

Answer Field

To buy Strides Pharma Science Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Strides Pharma Science Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 Lacs+ Users

icon-with-text

4.1+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5100+ Cr MTF Book

icon-with-text
loader